Richard Scolyer: The Cancer Specialist Who Tested Hope on Himself

A Diagnosis That Changed Everything

In 2023, Prof Richard Scolyer, one of the world’s leading cancer specialists and pathologist, was diagnosed with glioblastoma—the most aggressive and typically incurable type of primary brain cancer. Rather than accepting the standard course of palliative care in a 6-12 month lifespan, Scolyer chose to pursue an experimental path that would advance science and benefit both himself and future patients.

2025, Richard Scolyer recognized among 100 most influential people in Oncology by OncoDaily.

Turning Research into Treatment

Working alongside his longtime colleague, oncologist Professor Georgina Long, Scolyer adapted the groundbreaking immunotherapy strategies they had previously developed to treat advanced melanoma, to treat his own terminal brain tumor. The same groundbreaking immunotherapy strategy, had previously won the duo, The 2024 Australian of The Year Award. The treatment represented a world-first attempt to apply this approach to glioblastoma.

Melanoma pioneers, Professors Georgina Long and Richard Scolyer, awarded NSW’s 2024 Australians of the Year

A Promising Breakthrough

The experimental therapy produced encouraging early results. While glioblastoma typically recurs within six months, Scolyer’s scans remained free of tumor growth for nearly two years, offering hope that immunotherapy could play a future role in treating one of the deadliest brain cancers.

Professor Richard Scolyer and Professor Georgina Long in a pivotal moment reviewing an MRI brain scan

The Cancer Returns

Unfortunately, in March 2025, routine scans detected a recurrence of the tumor. Despite undergoing further chemotherapy and personalized immunotherapies aimed at slowing the tumor spread, the cancer progressed. Professor Richard Scolyer passed away peacefully on June 7, 2026, surrounded by his wife, Dr.Katie Nicholl and their 3 children.

A Legacy That Lives On

Although the treatment did not ultimately cure his cancer, Scolyer’s decision to become the first patient in his own experimental trial generated valuable scientific insights that continue to guide brain cancer research.

His selfless legacy is now immortalized not only through his transformation of melanoma from a death sentence into a manageable disease, but also through his courageous final act of turning himself into a living laboratory to advance cancer science and providing hope for future glioblastoma patients.


At Mastermind Medics Tv, we remain committed to bringing you the stories behind medical breakthroughs, celebrating the individuals whose courage and innovation continue to shape the future of healthcare.

Enjoyed this article? Follow Mastermind Medics Tv on all social platforms and share our stories to stay in the know with the latest medical news, research, and healthcare insights.

Oh hi there 👋
It’s nice to meet you.

Sign up to receive awesome content in your inbox.

We don’t spam! Read our privacy policy for more info.

Leave a Reply

Your email address will not be published. Required fields are marked *